Conformational aspects of human formyl-peptide receptor agonists

被引:0
|
作者
Dalpiaz, A
Vertuani, G
Scatturin, A
Vitali, F
Varani, K
Spisani, S
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Expt & Clin Med, I-44100 Ferrara, Italy
[3] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
来源
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2003年 / 53卷 / 11期
关键词
circular dichroism; formyl-peptide receptor agonists; chemotaxis; human neutrophils; peptide conformation;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The conformation of several Met-Ile-Phe-Leu analogues was analyzed using circular dichroism and infra-red absorption. Their effect on human neutrophils was verified toy receptor binding assays and measurements of lysozyme release. The results demonstrate that in amphipatic environments the compounds examined can be highly and weakly ordered in beta-turn structures, in dependence on their N-terminal substituents. The ability of the compounds to evoke neutrophil functions appears strongly and weakly influenced by N- and C-terminal modification, respectively.
引用
收藏
页码:793 / 798
页数:6
相关论文
共 50 条
  • [21] C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor
    Dalpiaz, A
    Ferretti, ME
    Vertuani, G
    Traniello, S
    Scatturin, A
    Spisani, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (03) : 187 - 196
  • [22] Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2
    Fabio Cattaneo
    Rosita Russo
    Martina Castaldo
    Angela Chambery
    Cristiana Zollo
    Gabriella Esposito
    Paolo Vincenzo Pedone
    Rosario Ammendola
    Scientific Reports, 9
  • [23] Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis
    Margraf, Andreas
    Chen, Jianmin
    Christoforou, Marilena
    Claria-Ribas, Pol
    Henriques Schneider, Ayda
    Cecconello, Chiara
    Bu, Weifeng
    Imbert, Paul R. C.
    Wright, Thomas D.
    Russo, Stefan
    Blacksell, Isobel A.
    Koenis, Duco S.
    Dalli, Jesmond
    Lupisella, John A.
    Wurtz, Nicholas R.
    Garcia, Ricardo A.
    Cooper, Dianne
    Norling, Lucy, V
    Perretti, Mauro
    EMBO MOLECULAR MEDICINE, 2025,
  • [24] Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in marine acute myocardial infarct
    Perretti, M
    Gavins, FNE
    Kamal, AM
    D'Amico, M
    Oliani, SM
    FASEB JOURNAL, 2005, 19 (04): : A707 - A707
  • [25] Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2
    Cattaneo, Fabio
    Russo, Rosita
    Castaldo, Martina
    Chambery, Angela
    Zollo, Cristiana
    Esposito, Gabriella
    Pedone, Paolo Vincenzo
    Ammendola, Rosario
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct
    Gavins, FNE
    Kamal, AM
    D'Amico, M
    Oliani, SM
    Perretti, M
    FASEB JOURNAL, 2004, 18 (13): : 100 - +
  • [27] MYELIN BASIC-PROTEIN INHIBITS FORMYL-PEPTIDE INDUCED CHEMOTAXIS IN HUMAN-NEUTROPHILS
    BELLINI, T
    DALLOCCHIO, F
    DEGANI, D
    SPISANI, S
    GAVIOLI, R
    TRANIELLO, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) : 524 - 527
  • [28] NEUTROPHIL FORMYL-PEPTIDE RECEPTORS - RELATIONSHIP TO PEPTIDE-INDUCED RESPONSES AND EMPHYSEMA
    STOCKLEY, RA
    GRANT, RA
    LLEWELLYNJONES, CG
    HILL, SL
    BURNETT, D
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (02) : 464 - 468
  • [29] Intracellular signaling triggered by formyl-peptide receptors in nonphagocytic cells
    Iaccio, Annalisa
    Angiolillo, Antonella
    Ammendola, Rosario
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2008, 3 (02) : 88 - 96
  • [30] Identification of formyl peptide receptor agonists through screening of a compound library
    Forsman, H.
    Kalderen, C.
    Nordin, A.
    Jensen, A. J.
    Dahlgren, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 38 - 38